Ana C. deCarvalho

5.7k total citations
44 papers, 2.0k citations indexed

About

Ana C. deCarvalho is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Ana C. deCarvalho has authored 44 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Genetics and 12 papers in Oncology. Recurrent topics in Ana C. deCarvalho's work include Glioma Diagnosis and Treatment (19 papers), Cancer Cells and Metastasis (8 papers) and Nanoplatforms for cancer theranostics (7 papers). Ana C. deCarvalho is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), Cancer Cells and Metastasis (8 papers) and Nanoplatforms for cancer theranostics (7 papers). Ana C. deCarvalho collaborates with scholars based in United States, Israel and Canada. Ana C. deCarvalho's co-authors include Tom Mikkelsen, Steven N. Kalkanis, Chaya Brodie, Cunli Xiang, Susan Finniss, Laila Poisson, Stephanie L. Lomonaco, John L. Teem, Félix Umansky and Lisa J. Gansheroff and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and PLoS ONE.

In The Last Decade

Ana C. deCarvalho

40 papers receiving 2.0k citations

Peers

Countries citing papers authored by Ana C. deCarvalho

Since Specialization

Citations

This map shows the geographic impact of Ana C. deCarvalho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana C. deCarvalho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana C. deCarvalho more than expected).

Fields of papers citing papers by Ana C. deCarvalho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana C. deCarvalho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana C. deCarvalho. The network helps show where Ana C. deCarvalho may publish in the future.

Co-authorship network of co-authors of Ana C. deCarvalho

This figure shows the co-authorship network connecting the top 25 collaborators of Ana C. deCarvalho. A scholar is included among the top collaborators of Ana C. deCarvalho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana C. deCarvalho. Ana C. deCarvalho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nanotherapy Targeting miR-10b Improves Survival in Orthotopic Glioblastoma Models 2025 ·Journal of Functional Biomaterials ·(unknown), (unknown), (unknown), Elizabeth Kenyon, Christiane L. Mallett, Ana C. deCarvalho, Zdravka Medarova, (unknown)	0
2	Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment 2025 ·PLoS ONE ·(unknown), (unknown), Indrani Datta, Kimberly Bergman, Thaís S. Sabedot, Katherine Gurdziel, Susan M. Irtenkauf, Laura Hasselbach, Yuling Meng, Claudius Mueller, Emanuel F. Petricoin, Stephen L. Brown, (unknown), (unknown), Tom Mikkelsen, Laila Poisson, Houtan Noushmehr, Douglas M. Ruden, Ana C. deCarvalho	0
3	A novel HPβCD-Cu(DDC)2 delivery system in patient derived orthotopic xenograft targeting MGMT-mediated temozolomide resistance in glioblastoma 2025 ·Scientific Reports ·Hamid Suhail, Md. Ataur Rahman, (unknown), (unknown), Ana C. deCarvalho, James R. Ewing, James M. Snyder, Meser M. Ali	0
4	Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles 2022 ·Scientific Reports ·(unknown), (unknown), Gage T. Mason, (unknown), (unknown), Mitchell DiPasquale, (unknown), (unknown), (unknown), Mohamed A. R. Soliman, Ana C. deCarvalho, (unknown), Swati Kulkarni, Drew Marquardt, Lisa A. Porter, Simon Rondeau‐Gagné	16
5	DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features 2021 ·Neuro-Oncology ·(unknown), Thaís S. Sabedot, Tiago C. Silva, Tathiane M. Malta, Felipe Segato Dezem, Karam Asmaro, Michael Wells, Abir Mukherjee, Laila Poisson, James M. Snyder, Ana C. deCarvalho, Tobias Walbert, (unknown), Steven N. Kalkanis, Paula Condé Lamparelli Elias, Sonir Roberto Rauber Antonini, Jack Rock, Houtan Noushmehr, Margaret de Castro, Ana Valeria Castro	14
6	Oncogenic extrachromosomal DNA functions as mobile enhancers to globally amplify chromosomal transcription 2021 ·Cancer Cell ·Yanfen Zhu, Amit D. Gujar, Chee‐Hong Wong, Harianto Tjong, Chew Yee Ngan, Liang Gong, Yi‐An Chen, Hoon Kim, Jihe Liu, (unknown), Adam Mil-Homens, Rahul Maurya, (unknown), Fanyue Sun, Eunhee Yi, Ana C. deCarvalho, Yijun Ruan, Roel G.W. Verhaak, Chia‐Lin Wei	144
7	MRI Monitoring of Cerebral Blood Flow after the Delivery of Nanocombretastatin across the Blood Brain Tumor Barrier 2018 ·Journal of Nanomedicine & Nanotechnology ·(unknown), Madhava Aryal, James R. Ewing, Ana C. deCarvalho, Steven N. Kalkanis, Meser M. Ali	5
8	Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells 2018 ·Cell chemical biology ·Kaoru Shimada, Eduard Reznik, Michael E. Stokes, Lakshmi Krishnamoorthy, Pieter H. Bos, Yuyu Song, (unknown), Nen C. Pagano, Darren R. Carpizo, Ana C. deCarvalho, Donald C. Lo, Brent R. Stockwell	84
9	Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma 2018 ·Nature Genetics ·Ana C. deCarvalho, Hoon Kim, Laila Poisson, Mary E. Winn, Claudius Mueller, David Cherba, Julie Koeman, Sahil Seth, Alexei Protopopov, Michelle M. Felicella, (unknown), Asha S. Multani, Yongying Jiang, Jianhua Zhang, Do‐Hyun Nam, Emanuel F. Petricoin, Lynda Chin, Tom Mikkelsen, Roel G.W. Verhaak	176
10	The Cyclin-like Protein Spy1 Regulates Growth and Division Characteristics of the CD133+ Population in Human Glioma 2014 ·Cancer Cell ·(unknown), Brenna A. Market-Velker, Ana C. deCarvalho, Tom Mikkelsen, Elizabeth Fidalgo da Silva, Lisa A. Porter	28
11	Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy 2014 ·Neoplasia ·Gregory J. Baker, Viveka Nand Yadav, Sébastien Motsch, Carl Koschmann, Anda‐Alexandra Calinescu, Yohei Mineharu, Sandra Camelo‐Piragua, Daniel A. Orringer, Serguei Bannykh, W. Stephen Nichols, Ana C. deCarvalho, Tom Mikkelsen, María G. Castro, Pedro R. Löwenstein	129
12	The selective Aurora-A kinase inhibitor MLN8237 (alisertib) potently inhibits proliferation of glioblastoma neurosphere tumor stem-like cells and potentiates the effects of temozolomide and ionizing radiation 2014 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), (unknown), James R. Van Brocklyn, (unknown), Dennis K. Pearl, Ana C. deCarvalho, Jeffrey Ecsedy, Stephen L. Brown, Tom Mikkelsen, Norman L. Lehman	46
13	Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation 2014 ·Neoplasia ·(unknown), Laila Poisson, David Cherba, Craig P. Webb, (unknown), Nancy Lemke, Hong Xin, Laura Hasselbach, Susan M. Irtenkauf, Tom Mikkelsen, Ana C. deCarvalho	123
14	Glioblastoma Cell Enrichment Is Critical for Analysis of Phosphorylated Drug Targets and Proteomic–Genomic Correlations 2013 ·Cancer Research ·Claudius Mueller, Ana C. deCarvalho, Tom Mikkelsen, Norman L. Lehman, Valerie Calvert, Virginia Espina, Lance A. Liotta, Emanuel F. Petricoin	36
15	Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo 2013 ·Chinese Journal of Cancer ·Adarsh Shankar, (unknown), Asm Iskander, Nadimpalli R. S. Varma, Branislava Janic, Ana C. deCarvalho, Tom Mikkelsen, Joseph A. Frank, Meser M. Ali, Robert A. Knight, Stephen L. Brown, Ali S. Arbab	36
16	Heparanase expression of glioma in human and animal models 2009 ·Journal of neurosurgery ·Hong Xin, Kevin Nelson, Ana C. deCarvalho, Steven N. Kalkanis	24
17	Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth 2007 ·Glia ·Ana C. deCarvalho, Xuepeng Zhang, Cynthia J. Roberts, Feng Jiang, Steven N. Kalkanis, Hong Xin, Mei Lü, Michael Chopp	13
18	EphB2 induces proliferation and promotes a neuronal fate in adult subventricular neural precursor cells 2005 ·Neuroscience Letters ·Mark Katakowski, Zhenggang Zhang, Ana C. deCarvalho, Michael Chopp	40
19	Low-dose photodynamic therapy increases endothelial cell proliferation and VEGF expression in nude mice brain 2005 ·Lasers in Medical Science ·Xuepeng Zhang, Feng Jiang, Zheng Gang Zhang, Steven N. Kalkanis, Hong Xin, Ana C. deCarvalho, Jieli Chen, (unknown), Adam Robin, Michael Chopp	28
20	Mutations in the Nucleotide Binding Domain 1 Signature Motif Region Rescue Processing and Functional Defects of Cystic Fibrosis Transmembrane Conductance Regulator ΔF508 2002 ·Journal of Biological Chemistry ·Ana C. deCarvalho, Lisa J. Gansheroff, John L. Teem	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact